OncoDecipher vs PhaseV
OncoDecipher vs PhaseV, compared side by side on 14 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: OncoDecipher is on 43/100 and PhaseV on 56/100.
Where each one leads
OncoDecipher
Leads on none of the measures we hold for both companies.
PhaseV
- our overall score: 56/100 against 43/100
- funding raised: $65.0M against $1.0M
At a glance
| Measure | OncoDecipher | PhaseV |
|---|---|---|
| What it is | OncoDecipher uses silent mutations in cancer genomes to predict cancer type and survival probability. | Develops a platform for adaptive clinical trial design and closed-loop execution. |
| Category | Life Sciences, Cancer, Oncology, Mutation | Life Sciences, Clinical Trials, Optimization, HealthTech |
| Sells toBusiness model | B2B | B2B |
| Offering | Software | Software |
| Founded | 2015 | 2023 |
| Headquarters | Cambridge, United States | Tel Aviv, Israel |
| Status | Inactive | Active |
Size, funding and growth
| Measure | OncoDecipher | PhaseV |
|---|---|---|
| Employees | Not published | 61 |
| Headcount growthLast 12 months | Not published | +173.2% |
| Total funding | $1.0M | $65.0M |
| Latest round | Seed | Series A |
| LinkedIn followers | Not published | 6,602 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | OncoDecipher | PhaseV |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 43/100 | 56/100 |
| Traction | 30/100 | 57/100 |
| Team | 60/100 | 70/100 |
| Search visibility | 3/100 | 40/100 |
| Quality | 52/100 | 55/100 |
| Agent readinessHow well an AI agent can read and act on the site | Not published | D (42/100) |
| Domain ratingLink authority, 0-100 | Not published | 33/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | OncoDecipher | PhaseV |
|---|---|---|
| CDN | Not detected | Cloudflare |
| CMS | Not detected | Webflow |
| Analytics | Not detected | Google Analytics 4 |
OncoDecipher vs PhaseV: common questions
Which is better, OncoDecipher or PhaseV?
On our 0-100 score PhaseV rates higher (56/100 against 43/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 14 data points above: read the rows that match what you are buying for.
How do OncoDecipher and PhaseV compare on the numbers?
PhaseV leads on our overall score (56/100 against 43/100), funding raised ($65.0M against $1.0M).
Read the full OncoDecipher review and pricing or the PhaseV review and pricing. You can also browse other OncoDecipher alternatives we track.